| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.22 | 0.0005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.07 |